Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.
3.

Treatment of the bleeding tendency in uremia with cryoprecipitate.

Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D.

N Engl J Med. 1980 Dec 4;303(23):1318-22.

PMID:
6776402
5.

IIB von Willebrand's disease: pathogenetic and therapeutic studies.

Kyrle PA, Niessner H, Dent J, Panzer S, Brenner B, Zimmerman TS, Lechner K.

Br J Haematol. 1988 May;69(1):55-9.

PMID:
3132965
6.

Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS.

N Engl J Med. 1983 Jan 6;308(1):8-12.

PMID:
6401193
7.

Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.

Rydzewski A, Rowiński M, Myśliwiec M.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(6):823-30.

PMID:
2436997
8.

1-Deamino-8-D-arginine vasopressin and cryoprecipitate in variant von Willebrand disease.

Hanna WT, Slywka J, Dent J, Ruggeri ZM, Zimmerman TS.

Am J Hematol. 1985 Oct;20(2):169-73.

PMID:
3929596
9.

Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia.

Viganò GL, Mannucci PM, Lattuada A, Harris A, Remuzzi G.

Am J Hematol. 1989 May;31(1):32-5.

PMID:
2705441
10.

Cryoprecipitate shortens the bleeding time and reduces bleeding complications in patients with uremia.

Jubelirer SJ, Janson PA, Weinstein MJ, Deykin D.

Trans Assoc Am Physicians. 1980;93:182-91. No abstract available.

PMID:
6787774
11.

Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.

Escolar G, Cases A, Monteagudo J, Garrido M, Lopez J, Ordinas A, Revert L, Castillo R.

J Lab Clin Med. 1989 Jul;114(1):36-42.

PMID:
2738447
12.

Cryoprecipitate for uremic bleeding.

Davenport R.

Clin Pharm. 1991 Jun;10(6):429. No abstract available.

PMID:
1905991
13.

Cryoprecipitate. Patterns of use.

Pantanowitz L, Kruskall MS, Uhl L.

Am J Clin Pathol. 2003 Jun;119(6):874-81.

PMID:
12817436
14.

The effect of desmopressin on massive gastrointestinal bleeding in hereditary telangiectasia unresponsive to treatment with cryoprecipitate.

Quitt M, Froom P, Veisler A, Falber V, Sova J, Aghai E.

Arch Intern Med. 1990 Aug;150(8):1744-6.

PMID:
2116786
15.

Hemostatic and fibrinolytic response to desmopressin in uremic patients.

Chen KS, Huang CC, Leu ML, Deng P, Lo SK.

Blood Purif. 1997;15(2):84-91.

PMID:
9087815
16.

Evidence-based treatment recommendations for uremic bleeding.

Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ.

Nat Clin Pract Nephrol. 2007 Mar;3(3):138-53. Review.

PMID:
17322926
17.

Management of uremic bleeding.

Couch P, Stumpf JL.

Clin Pharm. 1990 Sep;9(9):673-81. Review.

PMID:
2171866
18.

DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium.

Sakariassen KS, Cattaneo M, vd Berg A, Ruggeri ZM, Mannucci PM, Sixma JJ.

Blood. 1984 Jul;64(1):229-36.

19.

Intranasal deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

Shapiro MD, Kelleher SP.

Am J Nephrol. 1984;4(4):260-1.

PMID:
6332534
20.

Conjugated estrogens for the management of bleeding associated with renal failure.

Livio M, Mannucci PM, Viganò G, Mingardi G, Lombardi R, Mecca G, Remuzzi G.

N Engl J Med. 1986 Sep 18;315(12):731-5.

PMID:
3018561

Supplemental Content

Support Center